Aclaris Therapeutics
Price & Volume
Stats
See moreOpen | $1.43 |
Previous Close | $1.39 |
Day Range | $1.41-$1.52 |
52W Range | $1.05-$5.17 |
Market Cap | $150.5M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $17.7M |
Revenue Growth (YoY) | -39.3% |
Gross Profit (12 Mos) | -$32.6M |
Diluted EPS | -$1.59 |
News
See moreYahoo Finance • 28 days ago
Aclaris Therapeutics to Participate in Two June Healthcare Conferences
Yahoo Finance • 2 months ago
Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
Yahoo Finance • 4 months ago
Aclaris Therapeutics to Participate in Two March Healthcare Conferences
Yahoo Finance • 4 months ago
New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3
About
CEO | Dr. Neal S. Walker D.O., M.D. |
Address | 701 Lee Road, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
